Downgrades are outpacing upgrades in the not-for-profit hospital sector. Ratings analyst Lisa Goldstein discusses that trend, along with the impact of merger and acquisition activity.
Gilead Sciences’ move to launch generic versions of two hepatitis C treatments could motivate states to eliminate restrictions on their Medicaid and inmate populations.
As suicide reaches crisis-level proportions in our nation, it’s time to treat suicide like the public health crisis that it is, and healthcare leaders and executives play a critical role.
Fully integrating Amazon Business into Summit Pacific’s supply-chain operations has taken the hassle and some expense out of tedious procurement processes.
Academic medical centers will bear the brunt of the CMS’ proposed outpatient site-neutral policy should it be finalized, according to an analysis by the Integrated Health Care Coalition.
A key Senate committee approved Judge Brett Kavanaugh’s nomination to the Supreme Court, but a GOP lawmaker has called for a limited FBI investigation into allegations against President Donald Trump’s pick.
Average monthly premiums for Medicare Advantage will hit a three year low next year at $28 a month, according to the CMS. Plan enrollment is expected to rise to 22.6 million, encompassing more than 36% of Medicare beneficiaries.